These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 16905642)

  • 1. Serum cholesterol levels and the risk of Parkinson's disease.
    de Lau LM; Koudstaal PJ; Hofman A; Breteler MM
    Am J Epidemiol; 2006 Nov; 164(10):998-1002. PubMed ID: 16905642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease.
    Sohmiya M; Tanaka M; Tak NW; Yanagisawa M; Tanino Y; Suzuki Y; Okamoto K; Yamamoto Y
    J Neurol Sci; 2004 Aug; 223(2):161-6. PubMed ID: 15337618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of coenzyme Q10 in patients with Parkinson's disease.
    Jiménez-Jiménez FJ; Molina JA; de Bustos F; García-Redondo A; Gómez-Escalonilla C; Martínez-Salio A; Berbel A; Camacho A; Zurdo M; Barcenilla B; Enríquez de Salamanca R; Arenas J
    J Neural Transm (Vienna); 2000; 107(2):177-81. PubMed ID: 10847558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of coffee consumption and risk of Parkinson's disease.
    Sääksjärvi K; Knekt P; Rissanen H; Laaksonen MA; Reunanen A; Männistö S
    Eur J Clin Nutr; 2008 Jul; 62(7):908-15. PubMed ID: 17522612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes and the risk of Parkinson's disease.
    Hu G; Jousilahti P; Bidel S; Antikainen R; Tuomilehto J
    Diabetes Care; 2007 Apr; 30(4):842-7. PubMed ID: 17251276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total cholesterol and the risk of Parkinson disease.
    Hu G; Antikainen R; Jousilahti P; Kivipelto M; Tuomilehto J
    Neurology; 2008 May; 70(21):1972-9. PubMed ID: 18401018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum pro-oxidant and antioxidant factors and risk of Parkinson's disease: population study].
    Molina-Arjona JA; de Bustos F; Benito-León J; Jiménez-Jiménez FJ; Rodríguez J; Trincado R; Porta-Etessan J; Vega S; Bermejo F
    Rev Neurol; 1999 Jul 1-15; 29(1):12-5. PubMed ID: 10528302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease.
    de Lau LM; Stricker BH; Breteler MM
    Mov Disord; 2007 Oct; 22(13):1985. PubMed ID: 17557354
    [No Abstract]   [Full Text] [Related]  

  • 9. Body mass index and risk of Parkinson's disease: a prospective cohort study.
    Logroscino G; Sesso HD; Paffenbarger RS; Lee IM
    Am J Epidemiol; 2007 Nov; 166(10):1186-90. PubMed ID: 17709328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease.
    Shults CW; Flint Beal M; Song D; Fontaine D
    Exp Neurol; 2004 Aug; 188(2):491-4. PubMed ID: 15246848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Number of children and risk of Parkinson's disease.
    Frigerio R; Breteler MM; de Lau LM; Sanft KR; Bower JH; Ahlskog JE; Grossardt BR; ; Maraganore DM; Rocca WA
    Mov Disord; 2007 Apr; 22(5):632-9. PubMed ID: 17265462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coenzyme Q 10 and cardiovascular risk factors in idiopathic sudden sensorineural hearing loss patients.
    Cadoni G; Scipione S; Agostino S; Addolorato G; Cianfrone F; Leggio L; Paludetti G; Lippa S
    Otol Neurotol; 2007 Oct; 28(7):878-83. PubMed ID: 17558340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.
    Bornebroek M; de Lau LM; Haag MD; Koudstaal PJ; Hofman A; Stricker BH; Breteler MM
    Neuroepidemiology; 2007; 28(4):193-6. PubMed ID: 17851257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression.
    Ikeda K; Nakamura Y; Kiyozuka T; Aoyagi J; Hirayama T; Nagata R; Ito H; Iwamoto K; Murata K; Yoshii Y; Kawabe K; Iwasaki Y
    Neurodegener Dis; 2011; 8(4):252-8. PubMed ID: 21282940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson's disease.
    Isobe C; Murata T; Sato C; Terayama Y
    J Clin Neurosci; 2007 Apr; 14(4):340-3. PubMed ID: 16647853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incidence of idiopathic and secondary Parkinson disease in Navarre. Population-based case registry].
    Viñes JJ; Larumbe R; Gaminde I; Artázcoz MT
    Neurologia; 1999 Jan; 14(1):16-22. PubMed ID: 10079687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of lipid peroxides in patients with Parkinson's disease.
    Sanyal J; Bandyopadhyay SK; Banerjee TK; Mukherjee SC; Chakraborty DP; Ray BC; Rao VR
    Eur Rev Med Pharmacol Sci; 2009; 13(2):129-32. PubMed ID: 19499848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
    Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
    J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of serum cholesterol in Parkinson's disease: a meta-analysis of evidence.
    Gudala K; Bansal D; Muthyala H
    J Parkinsons Dis; 2013 Jan; 3(3):363-70. PubMed ID: 23948990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.